CytoSolv Raises $500,000 in Seed Funding

CytoSolv, Inc., a Providence, RI-based newly-formed biomedical developer of a technology to address wound healing, initially targeting diabetic ulcers, has received $500,000 in seed-stage funding from the Slater Technology Fund, a state-backed venture capital fund.
CytoSolv has generated promising pre-clinical data using its technology and plans to use the funds to pursue more advanced pre-clinical development in the year ahead.
The company was founded by Moses Goddard, M.D., and Christopher Thanos, Ph.D., based upon research to be published in the upcoming issue of scientific journal Cell Transplantation.
Dr. Goddard and Dr. Thanos have long-term affiliations with Brown University and have been actively engaged in several life science ventures based in Rhode Island.

Join the discussion